by Brain Haight | Jan 28, 2016 | News
Prodo Labs announces being the recipient of two new grants from the Qualifying Therapeutic Discovery Grant (QTDG) funds from a combined NIH/IRS program to provide stimulus funds to small businesses working to develop new health care products. The first grant is for...
by Brain Haight | Jan 28, 2016 | News
Prodo Labs publishes a new article in Transplantation Proceedings regarding its success in processing large quantities of human islets from research pancreas donors with long cold ischemia times. Prodo Labs has published its most recent results of processing and...
by Brain Haight | Jan 28, 2016 | News
Prodo Labs and the Scharp-Lacy Research Institute collaborate to increase the numbers of high quality human islets for distribution through a new contract with the National Institute for Diabetes, Digestive, and Kidney Diseases (NIDDK) of the National Institutes of...
by Brain Haight | Jan 28, 2016 | News
Prodo Labs announces cut back in activities due to reduced islet orders from the economic turndown. With slow down in the economy, major corporate pharmaceutical companies are changing their priorities in their research operations and reducing the number of human...
by Brain Haight | Jan 28, 2016 | News
Prodo Labs presented at the Rochmeil Levine Symposium A paper entitled, “USE OF ROCHE cGMP LIBERASE® MTF C/T IN ISLET ISOLATION FROM HUMAN PANCREAS WITH EXTENDED COLD ISCHEMIA TIME (CIT), was presented at the City of Hope annual Levine Symposium. It demonstrated...
